Primary and recurrent early stage laryngeal cancer: Preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose pet imaging

Val J. Lowe, Han Kim, James H. Boyd, John F. Elsenbeis, Frank R. Dunphy, James Fletcher

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

PURPOSE: To evaluate the effectiveness of 2-[fluorine 18]fluoro-2-deoxy- D-glucose (FDG) positron emission tomography (PET) in the identification of early stage (T1-T2) primary and recurrent laryngeal cancer. MATERIALS AND METHODS: Twelve patients with T1 or T2 laryngeal cancer underwent imaging prospectively with PET. Seven patients had new disease, and five had recurrent disease. All patients underwent imaging prior to planned therapy and tissue biopsy. PET images were evaluated by using standardized uptake ratios and visual analysis. RESULTS: Histopathologic evidence of early stage cancer was documented in the 12 patients. One had a carcinoma in situ, nine had T1 tumors, and two had T2 tumors. Of the 12 patients, 10 had vocal cord tumors, one had a hypopharyngeal tumor, and one had a preepiglottic tumor. Eleven (92%) patients with early stage cancer had standardized uptake ratios indicative of malignancy (mean, 4.6; SD, 1.8; 95% CI, 1.2; range, 2.8-7.6). One had false-negative results (standardized uptake ratio = 2.3). Nine underwent CT, and results in the larynx were normal in seven and abnormal in two. CONCLUSION: FDG PET can be used to identify primary and recurrent early stage laryngeal cancer. It may be useful for follow-up after therapy.

Original languageEnglish (US)
Pages (from-to)799-802
Number of pages4
JournalRadiology
Volume212
Issue number3
StatePublished - Sep 1999
Externally publishedYes

Fingerprint

Laryngeal Neoplasms
Fluorine
Pets
Deoxyglucose
Positron-Emission Tomography
Neoplasms
Vocal Cords
Carcinoma in Situ
Larynx
Cell- and Tissue-Based Therapy
Biopsy

Keywords

  • Emission CT (ECT), comparative studies
  • Fluorine, radioactive
  • Head and neck neoplasms
  • Head and neck neoplasms, emission CT (ECT)
  • Larynx, neoplasms

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Primary and recurrent early stage laryngeal cancer : Preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose pet imaging. / Lowe, Val J.; Kim, Han; Boyd, James H.; Elsenbeis, John F.; Dunphy, Frank R.; Fletcher, James.

In: Radiology, Vol. 212, No. 3, 09.1999, p. 799-802.

Research output: Contribution to journalArticle

Lowe, Val J. ; Kim, Han ; Boyd, James H. ; Elsenbeis, John F. ; Dunphy, Frank R. ; Fletcher, James. / Primary and recurrent early stage laryngeal cancer : Preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose pet imaging. In: Radiology. 1999 ; Vol. 212, No. 3. pp. 799-802.
@article{898553b4523d43e0aa235381b960b234,
title = "Primary and recurrent early stage laryngeal cancer: Preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose pet imaging",
abstract = "PURPOSE: To evaluate the effectiveness of 2-[fluorine 18]fluoro-2-deoxy- D-glucose (FDG) positron emission tomography (PET) in the identification of early stage (T1-T2) primary and recurrent laryngeal cancer. MATERIALS AND METHODS: Twelve patients with T1 or T2 laryngeal cancer underwent imaging prospectively with PET. Seven patients had new disease, and five had recurrent disease. All patients underwent imaging prior to planned therapy and tissue biopsy. PET images were evaluated by using standardized uptake ratios and visual analysis. RESULTS: Histopathologic evidence of early stage cancer was documented in the 12 patients. One had a carcinoma in situ, nine had T1 tumors, and two had T2 tumors. Of the 12 patients, 10 had vocal cord tumors, one had a hypopharyngeal tumor, and one had a preepiglottic tumor. Eleven (92{\%}) patients with early stage cancer had standardized uptake ratios indicative of malignancy (mean, 4.6; SD, 1.8; 95{\%} CI, 1.2; range, 2.8-7.6). One had false-negative results (standardized uptake ratio = 2.3). Nine underwent CT, and results in the larynx were normal in seven and abnormal in two. CONCLUSION: FDG PET can be used to identify primary and recurrent early stage laryngeal cancer. It may be useful for follow-up after therapy.",
keywords = "Emission CT (ECT), comparative studies, Fluorine, radioactive, Head and neck neoplasms, Head and neck neoplasms, emission CT (ECT), Larynx, neoplasms",
author = "Lowe, {Val J.} and Han Kim and Boyd, {James H.} and Elsenbeis, {John F.} and Dunphy, {Frank R.} and James Fletcher",
year = "1999",
month = "9",
language = "English (US)",
volume = "212",
pages = "799--802",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "3",

}

TY - JOUR

T1 - Primary and recurrent early stage laryngeal cancer

T2 - Preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose pet imaging

AU - Lowe, Val J.

AU - Kim, Han

AU - Boyd, James H.

AU - Elsenbeis, John F.

AU - Dunphy, Frank R.

AU - Fletcher, James

PY - 1999/9

Y1 - 1999/9

N2 - PURPOSE: To evaluate the effectiveness of 2-[fluorine 18]fluoro-2-deoxy- D-glucose (FDG) positron emission tomography (PET) in the identification of early stage (T1-T2) primary and recurrent laryngeal cancer. MATERIALS AND METHODS: Twelve patients with T1 or T2 laryngeal cancer underwent imaging prospectively with PET. Seven patients had new disease, and five had recurrent disease. All patients underwent imaging prior to planned therapy and tissue biopsy. PET images were evaluated by using standardized uptake ratios and visual analysis. RESULTS: Histopathologic evidence of early stage cancer was documented in the 12 patients. One had a carcinoma in situ, nine had T1 tumors, and two had T2 tumors. Of the 12 patients, 10 had vocal cord tumors, one had a hypopharyngeal tumor, and one had a preepiglottic tumor. Eleven (92%) patients with early stage cancer had standardized uptake ratios indicative of malignancy (mean, 4.6; SD, 1.8; 95% CI, 1.2; range, 2.8-7.6). One had false-negative results (standardized uptake ratio = 2.3). Nine underwent CT, and results in the larynx were normal in seven and abnormal in two. CONCLUSION: FDG PET can be used to identify primary and recurrent early stage laryngeal cancer. It may be useful for follow-up after therapy.

AB - PURPOSE: To evaluate the effectiveness of 2-[fluorine 18]fluoro-2-deoxy- D-glucose (FDG) positron emission tomography (PET) in the identification of early stage (T1-T2) primary and recurrent laryngeal cancer. MATERIALS AND METHODS: Twelve patients with T1 or T2 laryngeal cancer underwent imaging prospectively with PET. Seven patients had new disease, and five had recurrent disease. All patients underwent imaging prior to planned therapy and tissue biopsy. PET images were evaluated by using standardized uptake ratios and visual analysis. RESULTS: Histopathologic evidence of early stage cancer was documented in the 12 patients. One had a carcinoma in situ, nine had T1 tumors, and two had T2 tumors. Of the 12 patients, 10 had vocal cord tumors, one had a hypopharyngeal tumor, and one had a preepiglottic tumor. Eleven (92%) patients with early stage cancer had standardized uptake ratios indicative of malignancy (mean, 4.6; SD, 1.8; 95% CI, 1.2; range, 2.8-7.6). One had false-negative results (standardized uptake ratio = 2.3). Nine underwent CT, and results in the larynx were normal in seven and abnormal in two. CONCLUSION: FDG PET can be used to identify primary and recurrent early stage laryngeal cancer. It may be useful for follow-up after therapy.

KW - Emission CT (ECT), comparative studies

KW - Fluorine, radioactive

KW - Head and neck neoplasms

KW - Head and neck neoplasms, emission CT (ECT)

KW - Larynx, neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0032826578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032826578&partnerID=8YFLogxK

M3 - Article

C2 - 10478249

AN - SCOPUS:0032826578

VL - 212

SP - 799

EP - 802

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 3

ER -